IDE and Alzheimer disease: To examine the possibility that TLJN-induced Aβ reduction is also associated with Aβ degradation/or clearance in AD transgenic mice, we analyzed the levels of NEP and IDE in APP23 transgenic mouse brains with Western blotting.